[Erythromycin-ascorbinate therapy of pregnant rats with staphylococcal infections caused by staphylococcal strains both sensitive and resistant to erythromycin].
D000818:Animals; D001205:Ascorbic Acid / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D004917:Erythromycin / Q000627:therapeutic use*; D005260:Female; D005313:Fetal Death / Q000517:prevention & control; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D051381:Rats; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000401:mortality; D013210:Staphylococcus / Q000187:drug effects
D004917:Erythromycin; D001205:Ascorbic Acid
Lechenie  éritromitsin-askorbinatom beremennykh krys, porazhennykh stafilokokkovoĭ infektsiaĭ, vyzvannoĭ chuvstvitel'nym i rezistentnym k étomu antibiotiku shtammami stafilokkoka.